~ 1 in 10
couples face infertility, and undergo more than 2 million IVF cycles per year.
1 in 10
women has endometriosis, and approximately 40% struggle with infertility.
> 1 in 10
babies are born premature, and approximately 1 million of them die each year.
Freya empowers women through innovations that revolutionize reproductive health.
Freya™ is a clinical-stage company taking an innovative approach to women’s health, with microbial immunotherapies aimed at relieving the chronic inflammation underlying a range of reproductive system diseases uniquely afflicting women.
Restoring the reproductive and immune systems
Reproductive system disorders like embryo implantation failure, infertility among women with endometriosis and preterm birth share a common feature: local immune system dysregulation and inflammation caused by a dysbiotic microbiome.
- 1 in 3 women undergoing IVF have an inflammatory vaginal microbiome
- 1 in 10 women of reproductive age have endometriosis
- 1 in 4 of women have dysbiosis during pregnancy, increasing the risk for preterm birth
A human-first, data-driven approach
At Freya, we’re applying rigorous cutting edge science to address gaps in existing knowledge and shape a more comprehensive understanding of women’s health and disease. Fueled with ongoing clinical trial results, Freya’s in-human-first data science platform has the potential to quickly translate insights to effective therapeutic solutions.
- Microbiome: Quantitative & Whole Genome Sequencing
- 450+ proteomic immune markers
- 600+ transcriptomic immune markers
- Clinical outcomes & demographic data
- Data from 600+ women
- 100 full spectrum microbiota transplant interventions
Pipeline
| Stage one | Stage two | Stage three | Stage four | Stage five |
|---|
Program 1 (Indication)
Pellentesque non metus pharetra, mattis ante vitae, porttitor mi. Etiam sapien neque, pretium id mauris non, vehicula blandit ipsum. Morbi vitae ex mi. Aliquam nec massa at magna feugiat condimentum id in tortor. Suspendisse eget ultrices felis.
Program 2 (Indication)
Nunc purus nibh, sollicitudin sed vehicula vestibulum, posuere eget enim. Mauris scelerisque sapien eget ligula pretium laoreet. Phasellus ut fringilla leo. In luctus, lectus nec maximus lacinia, lectus tellus auctor odio, ac molestie quam dolor sit amet lectus. Sed sed ipsum vulputate, sagittis turpis ac, porta turpis.
Program 3 (Indication)
Mauris finibus metus ac ultrices eleifend. Sed iaculis in turpis eget aliquet. Maecenas aliquet suscipit sodales. Praesent sed augue ullamcorper, hendrerit nisi ac, mollis velit. Fusce maximus dapibus aliquet. Praesent accumsan eros sed metus pharetra accumsan.
Leadership
Colleen Acosta, PhD
CEO, Co-Founder
Colleen Acosta, PhD
CEO, Co-Founder
Morbi ac metus sed lectus gravida convallis cursus lobortis nibh. Integer dignissim quis justo ac molestie. Vivamus iaculis ligula vitae orci rutrum euismod. Pellentesque ultricies imperdiet elit a egestas. In vitae laoreet dolor, tincidunt ultrices libero. Fusce dapibus consectetur mauris, sit amet egestas nulla tincidunt quis. Vestibulum maximus egestas ante vitae finibus. Aliquam aliquet nisl a massa dictum gravida.
Proin iaculis tincidunt sollicitudin. Suspendisse aliquet tincidunt lacinia. Vivamus consectetur facilisis velit, eu cursus risus. Donec faucibus rutrum lorem. Maecenas non ornare velit. Donec placerat ac diam a rutrum.
Johan van Hylckama Vlieg, PhD
CSO, Co-Founder
Johan van Hylckama Vlieg, PhD
CSO, Co-Founder
Proin vestibulum ut odio non lacinia. Nam elementum fermentum ligula, porta iaculis augue blandit id. Pellentesque fermentum mattis viverra. Pellentesque dapibus felis et nisi fringilla, a ultrices metus molestie. Suspendisse ipsum nulla, vulputate id lacinia vitae, porttitor id metus. Aenean aliquet felis eu maximus tincidunt. Vestibulum condimentum urna mi, eu euismod purus condimentum ac.
Vestibulum aliquet vestibulum pharetra. Curabitur id luctus urna, eu ultricies risus. Fusce felis lorem, commodo id erat in, vulputate dignissim ante. Donec vel turpis ac purus tempus semper laoreet eget risus. Cras sed vulputate libero. Aliquam maximus risus ac lacus accumsan interdum. Nam ut urna fringilla, ornare ligula nec, congue quam. Vestibulum posuere, sapien porttitor dapibus commodo, nibh tellus fringilla ex, vitae eleifend tellus enim pulvinar dui. Nam eu placerat metus, vel aliquam mauris.
Per Cantor, MD, PhD
CMO
Per Cantor, MD, PhD
CMO
Duis vel lacus vel risus feugiat dignissim non eu ex. Nullam dignissim viverra nisl. Vestibulum sed felis vitae ligula aliquet aliquam. Quisque a magna ultricies, rhoncus enim in, luctus sapien. Donec tellus ipsum, congue ut semper vestibulum, tempor id mauris. Nullam convallis massa ac ante imperdiet aliquam.
Integer aliquet at tortor ac pretium. Nunc dui risus, semper id tellus ut, iaculis vestibulum ligula. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Etiam ac est in massa mattis sollicitudin non ullamcorper dui. Nunc vel malesuada nulla, vitae fermentum urna. Praesent a mauris ut mi imperdiet vestibulum.
Crilles Larsen, PhD Pharm
CTO
Crilles Larsen, PhD Pharm
CTO
Vivamus ut est in tellus pharetra malesuada. Mauris sollicitudin luctus nibh sed efficitur. Donec laoreet, leo eu pretium fringilla, felis orci consequat velit, sit amet congue sapien neque quis mi. Vivamus venenatis sit amet eros id pharetra. Sed nibh tortor, lacinia non lacinia id, placerat vitae nibh. Mauris consequat gravida odio a lacinia. Phasellus porta lacus in ante faucibus tempor.
Nunc faucibus leo sed lacinia rhoncus. Proin interdum ac ipsum in pellentesque. Nullam vehicula, odio vitae aliquet semper, nunc eros fermentum diam, vitae mollis nulla ex vel ligula. Cras eget dui pharetra erat accumsan aliquet. Aenean eu felis nisi.
Investors
Copyright © Freya
